Arcellx Overview

  • Founded
  • 2014
Founded
  • Status
  • Private
  • Latest Deal Type
  • Series B
  • Latest Deal Amount
  • $85M
Latest Deal Amount
  • Investors
  • 10

Arcellx General Information

Description

Operator of a privately held biopharmaceutical company intended to offer anti-tumor therapeutical services. The company develops first-in-class adaptive immune cell therapies that are readily silenced, activated and reprogrammed throughout the course of the disease, providing physicians with enhanced safety, improved efficacy, and expanded utility.

Contact Information

Website
Formerly Known As
Encarta Therapeutics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 25 West Watkins Mill Road
  • Suite A
  • Gaithersburg, MD 20878
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Arcellx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC (Series B) 14-Oct-2019 $85M 00000 Completed Pre-Clinical Trials
1. Early Stage VC (Series A) 17-Jan-2017 0000 0000 Completed Pre-Clinical Trials
To view Arcellx’s complete valuation and funding history, request access »

Arcellx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B-1 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B-2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00
Series A 29,795,227 $0.001000 8% $1 $1 1x $1 41.59%
To view Arcellx’s complete cap table history, request access »

Arcellx Executive Team (3)

Name Title Board Seat Contact Info
David Hilbert Ph.D Founder, President, Chief Executive Officer & Board Member
Han Lee Ph.D Chief Financial Officer
Angela Shen Chief Medical Officer
To view Arcellx’s complete executive team members history, request access »

Arcellx Board Members (8)

Name Representing Role Since
Ali Behbahani Self Board Member 000 0000
David Hilbert Ph.D Arcellx Founder, President, Chief Executive Officer & Board Member 000 0000
Derek Yoon AJU IB Investment Board Member 000 0000
Hugo Beekman AJU IB Investment Board Member 000 0000
Jill Carroll Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Arcellx Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
AJU IB Investment Venture Capital Minority 000 0000 000000 0
JVC Investment Partners Venture Capital Minority 000 0000 000000 0
LG Technology Ventures Corporate Venture Capital Minority 000 0000 000000 0
Mirae Asset Capital Other Minority 000 0000 000000 0
Mirae Asset Venture Investment PE/Buyout Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »